Skip to content

Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer

Assessment of Thiol Disulfide Balance in Early Stage Endometrium Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04175067
Enrollment
117
Registered
2019-11-22
Start date
2018-08-01
Completion date
2019-11-15
Last updated
2019-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrium Cancer, Oxidative Stress

Keywords

Early stage, thiol disulfide hemostasis, malignancy

Brief summary

The purpose of this study is to investigate thiol-disulfide balance in early stage endometrium cancer patients.

Detailed description

To date various oxidative stress paramaters were studied in patients with endometrial cancer, however dynamic thiol disulfide hemostasis has not been previously investigated. The thiol-disulfide balance in the circulation will be measured by the automated system created by Erel & Neselioglu(1). References 1- Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47:326-32. doi:10.1016/j.clinbiochem.2014.09.026.

Interventions

DIAGNOSTIC_TESTDisulphide(μmol/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry

Sponsors

Muğla Sıtkı Koçman University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

• Histopathologically confirmed diagnosis of stage I endometrium cancer

Exclusion criteria

* pulmonary disease * pulmonary hypertension * cardiac dysfunction * renal dysfunction * liver disease * chronic ishemia * systemic inflammation * concomitant malignancy * patients who use vitamin A,C or E (antioxidant vitamins) * patients who use smoke * patients who use drink alcohol * patients who use addictive for any drug

Design outcomes

Primary

MeasureTime frameDescription
native thiol/total thiol ratiopreoperative in the morning or preprandial for healthy volunteersnative thiol/total thiol ratio X (100 )
serum total thiol levelpreoperative in the morning or preprandial for healthy volunteersserum total thiol level in μmol/L
the disulphide/native thiol ratiopreoperative in the morning or preprandial for healthy volunteersthe disulphide/native thiol ratio X (100 )
disulphide/total thiol ratiopreoperative in the morning or preprandial for healthy volunteersdisulphide/total thiol ratio X (100 )
serum native thiol levelpreoperative in the morning or preprandial for healthy volunteersserum native thiol level in μmol/L
serum disulphide levelpreoperative in the morning or preprandial for healthy volunteersserum disulphide level in μmol/L

Secondary

MeasureTime frameDescription
total oxidant capacity (TOC)preoperative in the morning or preprandial for healthy volunteersTOC in mmol H2O2 equivalent/L.
Oxidative stress index (OSI)preoperative in the morning or preprandial for healthy volunteersOSI in mmol trolox/L.
total antioxidant capacity (TAC)preoperative in the morning or preprandial for healthy volunteersTAC in mmol trolox equivalent/L

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026